INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221,955 | -98.5% | 4,261 | -98.1% | 0.00% | -97.8% |
| Q2 2023 | $14,534,220 | +4112.8% | 229,536 | +2155.0% | 0.04% | +2150.0% |
| Q1 2021 | $345,000 | -13.8% | 10,179 | -60.8% | 0.00% | -33.3% |
| Q1 2020 | $400,000 | -84.3% | 26,000 | -86.8% | 0.00% | -66.7% |
| Q2 2019 | $2,555,000 | -13.7% | 196,803 | -19.0% | 0.01% | -18.2% |
| Q1 2019 | $2,960,000 | +30.1% | 243,003 | +21.6% | 0.01% | +10.0% |
| Q4 2018 | $2,276,000 | -65.3% | 199,803 | -33.9% | 0.01% | -58.3% |
| Q3 2018 | $6,561,000 | +12.8% | 302,348 | -8.1% | 0.02% | 0.0% |
| Q2 2018 | $5,814,000 | +27.4% | 329,048 | +51.8% | 0.02% | +14.3% |
| Q1 2018 | $4,563,000 | – | 216,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |